An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone posted that they want to try Melanotan 1 to prevent future sun damage and stop pre-cancerous skin lesions from coming back. They plan to have the existing lesions removed first, then use Melanotan 1 and watch whether new lesions recur. The person says they don’t want a dark tan; they hope a small initial tanning effect will be enough to provide ongoing protection. Melanotan 1 is a lab-made version of a naturally occurring tiny protein called a peptide. It acts on the body’s melanin system — the pigment that darkens skin. In simple terms, it nudges skin cells to make more melanin, which can darken the skin and, in theory, absorb some ultraviolet (UV) light from the sun. Melanotan 1 is different from commercial drugs like semaglutide; it’s a molecule aimed at pigmentation, not weight or metabolism. What the snippet describes is not a formal study. It sounds like an individual’s plan to try Melanotan 1 and monitor outcomes, not a controlled clinical trial. That means there’s no randomized group, no blinding, and likely few subjects (maybe just one). Scattered studies and anecdotes exist about Melanotan compounds increasing pigmentation and possibly reducing sunburn risk, but rigorous evidence that it prevents pre-cancerous lesions or skin cancer in people is limited or absent. The person’s idea — remove lesions, use the peptide, and watch for recurrence — could generate an observation but wouldn’t prove cause-and-effect by itself. Why anyone might care: if a treatment could safely boost natural pigmentation and reduce UV damage, it could offer an added layer of skin protection, especially for people at high risk of sun-related skin problems. For people who’ve had pre-cancerous lesions, anything that lowers recurrence would be attractive. Also, some want protection without a heavy tan, so the idea of a small, lasting increase in melanin is appealing. But that potential benefit is hypothetical based on the current note; it’s more an experimental plan than established medicine. There are important caveats and risks. Melanotan 1 is not an approved, well-tested preventive drug for skin cancer. Products sold online vary in purity and dosing, and self-experimentation carries risks. Increased pigmentation doesn’t eliminate the need for sunscreen, protective clothing, or regular dermatology checks. Possible side effects reported for related compounds include nausea, facial flushing, uneven pigmentation, and unknown long-term effects. People with certain health conditions or those on medications should be cautious. Because this is not a regulated clinical trial, results would be hard to interpret and safety monitoring may be inadequate. Bottom line: the idea of using Melanotan 1 to prevent recurrence of pre-cancerous skin lesions is an individual, unproven plan rather than proven medicine; it’s worth discussing with a dermatologist and, if pursued, doing so within a supervised clinical or medical context.
Source: r/Peptides